Kewaunee Scientific Corporation KEQU
Set alert
33.44 USD -0.07 -0.21%
At close · Oct 30
32.33 -1.11 -3.32%
After hours · Oct 30, 7:14 PM ET
32.52 Day range 33.75
32.10 52-week range 43.10
- YTD
- -10.61%
- 1 year
- -20.80%
- Open
- 33.20
- Prev close
- 33.51
- Mkt cap
- 96.82M
- Vol
- 10.13K
- Avg vol
- 3.52K
- EPS
- 2.76
- P/E
- 12.12
- Div yield
- 0.00%
More statistics
- Low
- 32.52
- High
- 33.75
- Forward P/E
- 24.86
- Beta
- 0.73
- Short ratio
- 2.16
- Inst. own
- 38.87%
- Dividend
- 0.00
- Ex-div date
- Sep 8, 2019
- 50-d avg
- 39.59
- 200-d avg
- 40.52
- 1y target
- 0.00
Financial health
Altman Z-Score
3.41 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 3
- Return on Equity 4
- Return on Assets 3
- Debt / Equity 2
- P/E 4
- P/B 4
Valuation
P/E 11.0×
FY 2017 5y median 8.0× FY 2026
P/S 0.4×
FY 2017 5y median 0.4× FY 2026
P/B 1.4×
FY 2017 5y median 1.4× FY 2026
P/FCF 7.2×
FY 2017 5y median 6.8× FY 2026
EV/EBITDA 5.2×
FY 2017 5y median 5.5× FY 2026
EV/Sales 0.4×
FY 2017 5y median 0.4× FY 2026
FCF Yield 13.9%
FY 2017 5y median 13.9% FY 2026
Profitability
Gross Margin 28.5%
FY 2017 5y median 25.5% FY 2026
Operating Margin 5.9%
FY 2017 5y median 5.9% FY 2026
Net Margin 3.4%
FY 2017 5y median 3.4% FY 2026
ROE 12.9%
FY 2017 5y median 12.9% FY 2026
ROIC 9.2%
FY 2017 5y median 9.2% FY 2026
ROA 5.4%
FY 2017 5y median 5.4% FY 2026
Growth (YoY)
Revenue 17.3%
FY 2017 FY 2026
Operating Income -5.9%
FY 2017 FY 2026
EPS (diluted) -15.9%
FY 2017 FY 2026
Free Cash Flow 16.5%
FY 2017 FY 2026
Financial Health
Current Ratio 2.2×
FY 2017 5y median 2.2× FY 2026
Quick Ratio 1.5×
FY 2017 5y median 1.6× FY 2026
Debt / Equity 0.4×
FY 2017 5y median 0.4× FY 2026
Net Debt / EBITDA 0.8×
FY 2017 5y median 0.8× FY 2026
Interest Coverage 4.3×
FY 2017 5y median 4.3× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-04-30